Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience

IntroductionReal-life experience with imipenem/cilastatin/relebactam (IMI/REL) for the treatment of KPC-producing Klebsiella pneumoniae complex (KPC-Kp) and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa (DTR-PA) infections is herein described.MethodsAdult patients with KPC-Kp or DTR-PA...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cristiana Leanza, Maria Teresa Mascellino, Lorenzo Volpicelli, Sara Covino, Antonio Falletta, Francesca Cancelli, Cristiana Franchi, Martina Carnevalini, Claudio M. Mastroianni, Alessandra Oliva
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-07-01
Col·lecció:	Frontiers in Microbiology
Matèries:	imipenem-relebactam KPC-producing Klebsiella pneumoniae imipenem/cilastatin/relebactam ceftazidime-avibactam resistance polymicrobial infections antimicrobial resistance
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1432296/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!